(Q34119504)

31 July 2017

Histone deacetylase inhibitors: novel anticancer agents (English)

1 reference

31 July 2017

Saunders NA

1

1 reference

31 July 2017

Popa C

2

1 reference

31 July 2017

Serewko MM

3

1 reference

31 July 2017

Jones SJ

4

1 reference

31 July 2017

Dicker AJ

5

1 reference

31 July 2017

Dahler AL

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Expert Opinion on Investigational Drugs

31 July 2017

1 reference

31 July 2017

8

1 reference

31 July 2017

1611-1621

1 reference

31 July 2017

10

1 reference

Transcriptional control. Sinful repression

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Histone acetylation and transcriptional regulatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

The TAF(II)250 subunit of TFIID has histone acetyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Characterization of a human RPD3 ortholog, HDAC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Three proteins define a class of human histone deacetylases related to yeast Hda1p

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

What's up and down with histone deacetylation and transcription?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Histone deacetylase activity is required for full transcriptional repression by mSin3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Fiber-derived butyrate and the prevention of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Histone acetylation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Conjunction dysfunction: CBP/p300 in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Retinoblastoma protein recruits histone deacetylase to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Role of the histone deacetylase complex in acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

E2F as a regulator of keratinocyte proliferation: implications for skin tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Retinoblastoma protein represses transcription by recruiting a histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Rb interacts with histone deacetylase to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Modulation of galectin-1 content in human head and neck squamous carcinoma cells by sodium butyrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Epidermal cell-shape regulation and subpopulation kinetics during butyrate-induced terminal maturation of normal and SV40-transformed human keratinocytes: epithelial models of differentiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Butyrate as a differentiating agent: pharmacokinetics, analogues and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1611

10.1517/13543784.8.10.1611

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference